Cem Akin

18.8k total citations · 2 hit papers
196 papers, 9.8k citations indexed

About

Cem Akin is a scholar working on Immunology, Rheumatology and Immunology and Allergy. According to data from OpenAlex, Cem Akin has authored 196 papers receiving a total of 9.8k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Immunology, 100 papers in Rheumatology and 75 papers in Immunology and Allergy. Recurrent topics in Cem Akin's work include Mast cells and histamine (182 papers), Urticaria and Related Conditions (70 papers) and Food Allergy and Anaphylaxis Research (64 papers). Cem Akin is often cited by papers focused on Mast cells and histamine (182 papers), Urticaria and Related Conditions (70 papers) and Food Allergy and Anaphylaxis Research (64 papers). Cem Akin collaborates with scholars based in United States, Austria and Germany. Cem Akin's co-authors include Dean D. Metcalfe, Peter Valent, Wolfgang R. Sperr, Mariana Castells, Michel Arock, Arnold S. Kirshenbaum, Karl Sotlar, Knut Brockow, Lawrence B. Schwartz and B. Jack Longley and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Cem Akin

190 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnostic criteria and classification of mastocytosis: a consensus proposal

2001 738 citations Peter Valent, B. Jack Longley et al. profile →
Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts

2016 394 citations Peter Valent, Cem Akin et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cem Akin United States	50	7.9k	4.7k	3.1k	1.5k	1.3k	196	9.8k
Joseph H. Butterfield United States	45	5.0k 0.6×	3.4k 0.7×	2.2k 0.7×	1.7k 1.1×	1.3k 1.0×	147	8.7k
Yoseph A. Mekori Israel	36	3.7k 0.5×	916 0.2×	1.7k 0.5×	1.5k 1.0×	1.4k 1.1×	147	6.0k
Timothy W. Behrens United States	61	8.2k 1.0×	5.3k 1.1×	243 0.1×	714 0.5×	3.1k 2.3×	128	13.0k
G. Kenneth Haines United States	43	2.3k 0.3×	1.6k 0.3×	1.1k 0.4×	357 0.2×	2.1k 1.6×	92	6.6k
Hisanori Umehara Japan	47	1.8k 0.2×	3.0k 0.6×	271 0.1×	1.1k 0.7×	2.6k 2.0×	158	7.8k
David Chantry United States	35	3.0k 0.4×	870 0.2×	636 0.2×	489 0.3×	1.1k 0.8×	74	5.5k
Timothy J. Vyse United Kingdom	44	5.7k 0.7×	3.7k 0.8×	293 0.1×	370 0.2×	1.7k 1.3×	121	8.6k
Paola Migliorini Italy	42	2.4k 0.3×	2.0k 0.4×	339 0.1×	310 0.2×	1.3k 1.0×	183	5.2k
Scott R. Barnum United States	45	3.2k 0.4×	345 0.1×	319 0.1×	795 0.5×	1.5k 1.1×	132	6.2k
Jane R. Parnes United States	38	3.5k 0.4×	260 0.1×	1.2k 0.4×	2.0k 1.3×	1.4k 1.0×	103	6.6k

Countries citing papers authored by Cem Akin

Since Specialization

Citations

This map shows the geographic impact of Cem Akin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cem Akin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cem Akin more than expected).

Fields of papers citing papers by Cem Akin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cem Akin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cem Akin. The network helps show where Cem Akin may publish in the future.

Co-authorship network of co-authors of Cem Akin

This figure shows the co-authorship network connecting the top 25 collaborators of Cem Akin. A scholar is included among the top collaborators of Cem Akin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cem Akin. Cem Akin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaakati, Rayan, et al.. (2024). Demographics, Types of Patient-Reported Allergic Diseases, and Anaphylaxis in Mastocytosis: A Single-Center US Experience. The Journal of Allergy and Clinical Immunology In Practice. 13(2). 398–406. 3 indexed citations

Akin, Cem, Frank Siebenhaar, Joshua B. Wechsler, Bradford A. Youngblood, & Marcus Maurer. (2024). Detecting Changes in Mast Cell Numbers Versus Activation in Human Disease: A Roadblock for Current Biomarkers?. The Journal of Allergy and Clinical Immunology In Practice. 12(7). 1727–1737. 6 indexed citations

Valent, Peter, Cem Akin, & Michel Arock. (2024). Reversible Elevation of Tryptase Over the Individual's Baseline: Why is It the Best Biomarker for Severe Systemic Mast Cell Activation and MCAS?. Current Allergy and Asthma Reports. 24(3). 133–141. 4 indexed citations

Akin, Cem. (2023). Tyrosine Kinase Inhibitors in Non-advanced Systemic Mastocytosis. Immunology and Allergy Clinics of North America. 43(4). 743–750. 7 indexed citations

Valent, Peter, Cem Akin, Michel Arock, et al.. (2023). Antibody-Based and Cell Therapies for Advanced Mastocytosis: Established and Novel Concepts. International Journal of Molecular Sciences. 24(20). 15125–15125. 1 indexed citations

Bose, Prithviraj, Stephen T. Oh, Brian D. Modena, et al.. (2023). Initial Results from Summit: An Ongoing, 3-Part, Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Study of Bezuclastinib in Adult Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM). Blood. 142(Supplement 1). 77–77. 3 indexed citations

González‐de‐Olano, David, et al.. (2023). Disease Spectrum of Anaphylaxis Disorders. The Journal of Allergy and Clinical Immunology In Practice. 11(7). 1989–1996. 10 indexed citations

Valent, Peter, Cem Akin, Karin Hartmann, et al.. (2022). Drug-induced mast cell eradication: A novel approach to treat mast cell activation disorders?. Journal of Allergy and Clinical Immunology. 149(6). 1866–1874. 17 indexed citations

Maurer, Marcus, Vito Sabato, Katrin Hartmann, et al.. (2020). Results from PIONEER: A randomized, double-blind, placebo-controlled, phase 2 study of avapritinib in patients with indolent systemic mastocytosis (ISM). University of Southern Denmark Research Portal (University of Southern Denmark). 1 indexed citations

10.

Otani, Iris M., Ryan W. Carroll, Phoebe H. Yager, et al.. (2018). Diffuse cutaneous mastocytosis with novel somatic KIT mutation K509I and association with tuberous sclerosis. Clinical Case Reports. 6(9). 1834–1840. 9 indexed citations

11.

Reiter, Alfred, Hanneke C. Kluin‐Nelemans, Cem Akin, et al.. (2017). Pooled Survival Analysis Of Midostaurin Clinical Study Data (D2201+A2213) In Patients With Advanced Systemic Mastocytosis Compared With Historical Controls. Haematologica. 7 indexed citations

12.

Valent, Peter, Cem Akin, & Dean D. Metcalfe. (2016). Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts. Blood. 129(11). 1420–1427. 394 indexed citations breakdown →

13.

Arock, Michel, Hanneke C. Kluin‐Nelemans, Wolfgang R. Sperr, et al.. (2016). Advanced systemic mastocytosis: from molecular and genetic progress to clinical practice. Haematologica. 101(10). 1133–1143. 35 indexed citations

14.

Arock, Michel, Cem Akin, Olivier Hermine, & Peter Valent. (2015). Current treatment options in patients with mastocytosis: status in 2015 and future perspectives. European Journal Of Haematology. 94(6). 474–490. 43 indexed citations

15.

Akin, Cem, et al.. (2015). Preoperative anxiety and postoperative pain in patients undergoing septoplasty.. PubMed. 11(1). 19–23. 22 indexed citations

16.

Theoharides, Theoharis C., Peter Valent, & Cem Akin. (2015). Mast Cells, Mastocytosis, and Related Disorders. New England Journal of Medicine. 373(2). 163–172. 328 indexed citations

17.

Marić, Irina, Jamie Robyn, Dean D. Metcalfe, et al.. (2007). KIT D816V–associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. Journal of Allergy and Clinical Immunology. 120(3). 680–687. 75 indexed citations

18.

Akin, Cem, Knut Brockow, Claudio D’Ambrosio, et al.. (2003). Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Experimental Hematology. 31(8). 686–692. 185 indexed citations

19.

Escribano, L., et al.. (2002). Mastocytosis: current concepts in diagnosis and treatment. Annals of Hematology. 81(12). 677–690. 143 indexed citations

20.

Akin, Cem, Arnold S. Kirshenbaum, Tekli Semere, et al.. (2000). Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis. Experimental Hematology. 28(2). 140–147. 139 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact